Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 66
Filter
1.
Mucosal Immunol ; 9(4): 907-16, 2016 07.
Article in English | MEDLINE | ID: mdl-26601902

ABSTRACT

Secretory IgA (SIgA) directed against gut resident bacteria enables the mammalian mucosal immune system to establish homeostasis with the commensal gut microbiota after weaning. Germinal centers (GCs) in Peyer's patches (PPs) are the principal inductive sites where naive B cells specific for bacterial antigens encounter their cognate antigens and receive T-cell help driving their differentiation into IgA-producing plasma cells. We investigated the role of antigen sampling by intestinal M cells in initiating the SIgA response to gut bacteria by developing mice in which receptor activator of nuclear factor-κB ligand (RANKL)-dependent M-cell differentiation was abrogated by conditional deletion of Tnfrsf11a in the intestinal epithelium. Mice without intestinal M cells had profound delays in PP GC maturation and emergence of lamina propria IgA plasma cells, resulting in diminished levels of fecal SIgA that persisted into adulthood. We conclude that M-cell-mediated sampling of commensal bacteria is a required initial step for the efficient induction of intestinal SIgA.


Subject(s)
B-Lymphocytes/immunology , Gastrointestinal Microbiome/immunology , Germinal Center/immunology , Immunoglobulin A, Secretory/metabolism , Intestinal Mucosa/physiology , Peyer's Patches/immunology , T-Lymphocytes, Helper-Inducer/immunology , Animals , Antigen Presentation , Antigens, Bacterial/immunology , Cell Differentiation , Cells, Cultured , Homeostasis , Immunity, Humoral , Immunity, Mucosal , Mice , Mice, Inbred C57BL , Mice, Knockout , Receptor Activator of Nuclear Factor-kappa B/genetics , Symbiosis
2.
Mucosal Immunol ; 6(4): 666-77, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23695511

ABSTRACT

The transcytosis of antigens across the gut epithelium by microfold cells (M cells) is important for the induction of efficient immune responses to some mucosal antigens in Peyer's patches. Recently, substantial progress has been made in our understanding of the factors that influence the development and function of M cells. This review highlights these important advances, with particular emphasis on: the host genes which control the functional maturation of M cells; how this knowledge has led to the rapid advance in our understanding of M-cell biology in the steady state and during aging; molecules expressed on M cells which appear to be used as "immunosurveillance" receptors to sample pathogenic microorganisms in the gut; how certain pathogens appear to exploit M cells to infect the host; and finally how this knowledge has been used to specifically target antigens to M cells to attempt to improve the efficacy of mucosal vaccines.


Subject(s)
Intestinal Mucosa/cytology , Intestinal Mucosa/immunology , Peyer's Patches/cytology , Peyer's Patches/immunology , Age Factors , Animals , Antigens/immunology , Antigens/metabolism , Antigens, Surface/immunology , Antigens, Surface/metabolism , Cell Communication/immunology , Cell Differentiation , Host-Pathogen Interactions/immunology , Humans , Intestinal Mucosa/metabolism , Monitoring, Immunologic , Peyer's Patches/metabolism , RANK Ligand/metabolism , Receptors, G-Protein-Coupled/metabolism , Stem Cells/cytology , Stem Cells/metabolism , Transcription Factors/metabolism
3.
Mucosal Immunol ; 6(5): 1027-37, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23360902

ABSTRACT

The transcytosis of antigens across the follicle-associated epithelium (FAE) of Peyer's patches by microfold cells (M cells) is important for the induction of efficient immune responses to mucosal antigens. The mucosal immune response is compromised by ageing, but effects on M cells were unknown. We show that M-cell density in the FAE of aged mice was dramatically reduced. As a consequence, aged Peyer's patches were significantly deficient in their ability to transcytose particulate lumenal antigen across the FAE. Ageing specifically impaired the expression of Spi-B and the downstream functional maturation of M cells. Ageing also dramatically impaired C-C motif chemokine ligand 20 expression by the FAE. As a consequence, fewer B cells were attracted towards the FAE, potentially reducing their ability to promote M-cell maturation. Our study demonstrates that ageing dramatically impedes the functional maturation of M cells, revealing an important ageing-related defect in the mucosal immune system's ability to sample lumenal antigens.


Subject(s)
Aging/immunology , Epithelial Cells/immunology , Peyer's Patches/metabolism , Animals , Antigens/metabolism , Cell Differentiation , Cells, Cultured , Chemokine CCL20/genetics , Chemokine CCL20/metabolism , Down-Regulation , Immunity, Mucosal , Mice , Mice, Inbred C57BL , Mucous Membrane/metabolism , Peyer's Patches/cytology , Proto-Oncogene Proteins c-ets/genetics , Proto-Oncogene Proteins c-ets/metabolism , Transcytosis/physiology
4.
Mucosal Immunol ; 5(2): 216-25, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22294048

ABSTRACT

Many prion diseases are orally acquired. Our data show that after oral exposure, early prion replication upon follicular dendritic cells (FDC) in Peyer's patches is obligatory for the efficient spread of disease to the brain (termed neuroinvasion). For prions to replicate on FDC within Peyer's patches after ingestion of a contaminated meal, they must first cross the gut epithelium. However, the mechanism through which prions are conveyed into Peyer's patches is uncertain. Within the follicle-associated epithelium overlying Peyer's patches are microfold cells (M cells), unique epithelial cells specialized for the transcytosis of particles. We show that following M cell-depletion, early prion accumulation upon FDC in Peyer's patches is blocked. Furthermore, in the absence of M cells at the time of oral exposure, neuroinvasion and disease development are likewise blocked. These data suggest M cells are important sites of prion uptake from the gut lumen into Peyer's patches.


Subject(s)
Brain/metabolism , Dendritic Cells, Follicular/immunology , Enterocytes/pathology , Peyer's Patches/immunology , Prion Diseases/immunology , Prions/immunology , RANK Ligand/immunology , Administration, Oral , Animals , Brain/immunology , Brain/pathology , Cell Differentiation/genetics , Cells, Cultured , Dendritic Cells, Follicular/pathology , Disease Progression , Eating , Enterocytes/immunology , Enterocytes/metabolism , Environmental Exposure/adverse effects , Meat , Mice , Mice, Knockout , Peyer's Patches/pathology , Prion Diseases/pathology , Prion Diseases/prevention & control , Prion Diseases/transmission , Transcytosis/genetics , Transcytosis/immunology
5.
Clin Exp Immunol ; 160(3): 440-9, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20148914

ABSTRACT

The chemokine receptor CCR6 is expressed by dendritic cells, B and T cells predominantly within the organized structures of the gut-associated lymphatic tissue. Its ligand CCL20 is synthesized by the follicle-associated epithelium and is crucial for the development of M cells within Peyer's patches. In addition, lineage-negative c-kit positive lymphocytes within cryptopatches (CP) express CCR6. CCR6-deficient mice exhibit an altered intestinal immune system containing increased amounts of intraepithelial lymphocytes and show smaller Peyer's patches, while progression of cryptopatches to mature isolated lymphoid follicles (ILF) is inhibited. In this report, we show that lin(-) c-kit(+) lymphocytes express a variety of different chemokine receptors and that CCR6 identifies those cells located within CP. In contrast, cells found outside CP are positive for CXCR3 and exhibit a different surface marker profile, suggesting that at least two different populations of lin(-) c-kit(+) cells are present. The presence of CCR6 does not influence the expression of Notch molecules on lin(-) c-kit(+) cells, nor does it influence Notch ligand expression on bone marrow-derived dendritic cells. In the human gut, CCR6 identifies clusters of lymphocytes resembling murine CP. CCR6 seems to have an important role for lin(-) c-kit(+) cells inside CP, is expressed in a regulated manner and identifies potential human CP.


Subject(s)
Epithelium/immunology , Immunity, Mucosal/physiology , Peyer's Patches/immunology , Receptors, CCR6/immunology , Animals , Antigens, Differentiation/genetics , Antigens, Differentiation/immunology , Chemokine CCL20/genetics , Chemokine CCL20/immunology , Humans , Mice , Mice, Knockout , Receptors, CCR6/genetics , Receptors, CXCR3/genetics , Receptors, CXCR3/immunology , Receptors, Notch/genetics , Receptors, Notch/immunology
6.
Am J Transplant ; 6(11): 2563-71, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16952298

ABSTRACT

We hypothesized that lymphoid organs within intestinal allografts contribute to their immunogenicity. Consistent with this hypothesis recipient T cells rapidly migrated to the lymph nodes and Peyer's patches of syngeneic and allogeneic intestinal grafts such that at 24 h approximately 50% of the lymphocytes isolated from donor lymphoid organs were of recipient origin. However, only in the lymphoid organs of allografts did recipient T cells display an activated phenotype, proliferate and produce IFNgamma. Rejection of allogeneic intestines lacking lymphoid organs was dramatically impaired in splenectomized, lymph node-deficient recipients compared to lymph node bearing, wild-type allogeneic intestines. This demonstrates the important role of donor lymphoid organs in the rejection process. Furthermore, recipient T cells proliferated more extensively and produced more IFNgamma in donor lymphoid organs than in recipient lymphoid organs, indicating that donor lymphoid organs play a dominant role in initiating the recipient anti-donor immune response following intestinal transplantation.


Subject(s)
Intestines/transplantation , T-Lymphocytes/immunology , Tissue Donors , Transplantation, Homologous/immunology , Animals , Flow Cytometry , Genotype , Graft Rejection/immunology , Lymphocyte Activation , Mice , Mice, Inbred C3H , Mice, Inbred C57BL , Models, Animal , Peyer's Patches/immunology
7.
Gut ; 54(11): 1565-72, 2005 Nov.
Article in English | MEDLINE | ID: mdl-15987794

ABSTRACT

AIM: Neutrophil migration in the intestine depends on chemotaxis of neutrophils to CXC chemokines produced by epithelial cells. The goal of this project was to determine if acute induction of a CXC chemokine gradient originating from intestinal epithelial cells is sufficient to induce neutrophil influx into intact intestinal tissue. METHODS AND RESULTS: The authors developed a double transgenic mouse model with doxycycline induced human IL-8 expression restricted to intestinal epithelial cells. Doxycycline treatment of double transgenic mice for three days resulted in a 50-fold increase in the caecal IL-8 concentration and influx of neutrophils into the lamina propria. Although neutrophils entered the paracellular space between epithelial cells, complete transepithelial migration was not observed. Doxycycline treatment also increased the water content of the caecal and colonic stool, indicating dysfunctional water transport. However, the transmural electrical resistance was not decreased. Neutrophils recruited to the intestinal epithelium did not show evidence of degranulation and the epithelium remained intact as judged by histology. CONCLUSIONS: This conditional transgenic model of chemokine expression provides evidence that acute induction of IL-8 in the intestinal epithelium is sufficient to trigger neutrophil recruitment to the lamina propria, but additional activation signals are needed for full activation and degranulation of neutrophils, mucosal injury, and complete transepithelial migration.


Subject(s)
Interleukin-8/biosynthesis , Intestinal Mucosa/immunology , Neutrophil Infiltration/immunology , Animals , Anti-Bacterial Agents/pharmacology , Body Water/metabolism , Cecum/immunology , Chemotaxis, Leukocyte/immunology , Colon/immunology , Doxycycline/pharmacology , Feces/chemistry , Humans , Immunity, Mucosal/drug effects , Immunity, Mucosal/immunology , Mice , Mice, Transgenic , Neutrophil Infiltration/drug effects , Neutrophils/immunology , Neutrophils/ultrastructure , Tetracycline/pharmacology
8.
Addiction ; 99(4): 498-508, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15049749

ABSTRACT

AIMS: To establish predictors of age 21 alcohol-related harm from prior drinking patterns, current levels of alcohol consumption and use of controlled drinking strategies. PARTICIPANTS: One thousand, five hundred and ninety-six students recruited from an initial sample of 3300 during their final year of high school in 1993. DESIGN: Longitudinal follow-up across five waves of data collection. SETTING: Post high school in Victoria, Australia. MEASUREMENTS: Self-administered surveys examining a range of health behaviours, including alcohol consumption patterns and related behaviour. FINDINGS: Drinking behaviours at age 21 were found to be strongly predicted by drinking trajectories established through the transition from high school. Multivariate regression analysis revealed that alcohol-related harms at age 21 were reduced where current levels of alcohol use fell within limits recommended in Australian national guidelines. After controlling for this effect it was found that the range of strategies employed by participants to control alcohol use maintained a small protective influence. Post-high-school drinking trajectories continued to demonstrate a significant effect after controlling for current behaviours. FINDINGS: revealed that over one quarter of males and females drank alcohol, but on a less-than-weekly basis. This pattern of alcohol use demonstrated considerable stability through the post-school transition and was associated with a low level of subsequent harm at age 21. CONCLUSIONS: Future research should investigate whether encouraging more Australian adolescents to drink alcohol on a less-than-weekly basis may be a practical intervention target for reducing alcohol-related harms.


Subject(s)
Alcohol Drinking/adverse effects , Alcohol-Related Disorders/prevention & control , Health Knowledge, Attitudes, Practice , Adolescent , Adolescent Behavior/psychology , Adult , Alcohol Drinking/epidemiology , Female , Follow-Up Studies , Humans , Longitudinal Studies , Male , Sex Distribution , Students/psychology , Surveys and Questionnaires , Victoria/epidemiology
9.
Blood ; 97(12): 3910-8, 2001 Jun 15.
Article in English | MEDLINE | ID: mdl-11389034

ABSTRACT

The molecular cloning of the t(5;10)(q33;q22) associated with atypical chronic myeloid leukemia (CML) is reported. Fluorescence in situ hybridization (FISH), Southern blot, and reverse transcriptase- polymerase chain reaction analysis demonstrated that the translocation resulted in an H4/platelet-derived growth factor receptor betaR (PDGFbetaR) fusion transcript that incorporated 5' sequences from H4 fused in frame to 3' PDGFbetaR sequences encoding the transmembrane, WW-like, and tyrosine kinase domains. FISH combined with immunophenotype analysis showed that t(5;10)(q33;q22) was present in CD13(+) and CD14(+) cells but was not observed in CD3(+) or CD19(+) cells. H4 has previously been implicated in pathogenesis of papillary thyroid carcinoma as a fusion partner of RET. The H4/RET fusion incorporates 101 amino acids of H4, predicted to encode a leucine zipper dimerization domain, whereas the H4/PDGFbetaR fusion incorporated an additional 267 amino acids of H4. Retroviral transduction of H4/PDGFbetaR, but not a kinase-inactive mutant, conferred factor-independent growth to Ba/F3 cells and caused a T-cell lymphoblastic lymphoma in a murine bone marrow transplantation assay of transformation. Mutational analysis showed that the amino-terminal H4 leucine zipper domain (amino acids 55-93), as well as H4 amino acids 101 to 386, was required for efficient induction of factor-independent growth of Ba/F3 cells. Tryptophan-to-alanine substitutions in the PDGFbetaR WW-like domain at positions 566/593, or tyrosine-to-phenylalanine substitutions at PDGFbetaR positions 579/581 impaired factor-independent growth of Ba/F3 cells. H4/PDGFbetaR is an oncoprotein expressed in t(5;10)(q33;q22) atypical CML and requires dimerization motifs in the H4 moiety, as well as residues implicated in signal transduction by PDGFbetaR, for efficient induction of factor-independent growth of Ba/F3 cells. (Blood. 2001;97:3910-3918)


Subject(s)
Carcinoma, Papillary/genetics , Chromosomes, Human, Pair 10 , Chromosomes, Human, Pair 5 , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics , Proteins/genetics , Receptor, Platelet-Derived Growth Factor beta/genetics , Thyroid Neoplasms/genetics , Translocation, Genetic , Cell Transformation, Neoplastic/genetics , Chromosomes, Human, Pair 10/genetics , Chromosomes, Human, Pair 5/genetics , Cloning, Molecular , Cytogenetic Analysis , Cytoskeletal Proteins , DNA, Neoplasm/genetics , DNA, Neoplasm/isolation & purification , Gene Rearrangement , Humans , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/etiology , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology , Mutagenesis , Myeloid Cells/metabolism , Myeloid Cells/pathology , Oncogene Proteins, Fusion , Protein Structure, Tertiary , Proteins/metabolism , Transfection
10.
Proc Inst Mech Eng H ; 215(2): 171-9, 2001.
Article in English | MEDLINE | ID: mdl-11382076

ABSTRACT

Fourteen pairs of explanted low contact stress (LCS) tibial interface components: six rotating platform (RP), six meniscal (MN) and two anterior-posterior (AP) glide designs, have been analysed with particular attention paid to the condition of the tibial counterfaces. The average surface roughness, Ra, for the tibial trays ranged from 0.01 to 0.087 micron, significantly greater than the unworn control measurement of 0.008 micron. The scratch geometry analysis showed that the scratch peaks were found to be consistently of a lower aspect ratio than the scratch valleys and under 1 micron in height (average asperity height Rp = 0.52 micron, aspect ratio delta p = 0.01, average asperity depth Rv = 1.10 microns, delta v = 0.05). The largest scratches were 3-4 microns in both Rp and Rv. In vitro tests have shown that ultra-high molecular weight polyethylene (UHMWPE) wear increases in the presence of counterface scratches perpendicular to the direction of motion. In these explants, the unidirectional motion produced scratches parallel to the direction of sliding which is predicted to produce a smaller increase in UHMWPE wear. Other designs in mobile bearing knees have less constrained motion at the tibial counterface and this has been shown to accelerate wear; it may also lead to a further increase in wear in the presence of third body scratches. It may be possible in future knee designs to reduce this type of wear damage by introducing alternative materials or coatings which are more resistant to scratching and surface roughening.


Subject(s)
Knee Prosthesis/adverse effects , Materials Testing , Polyethylenes/analysis , Tibia , Aged , Equipment Design , Female , Friction , Humans , In Vitro Techniques , Male , Middle Aged , Motion , Particle Size , Prosthesis Failure , Stress, Mechanical
11.
Parasite Immunol ; 23(3): 133-40, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11240904

ABSTRACT

Interleukin (IL)-7 is produced early in Schistosoma mansoni-infected human and murine skin and was recently shown to favour parasite development. In the present work, we investigated the participation of keratinocyte-derived IL-7 in this process. Keratinocytes are the predominant cellular constituents of the epidermis and the first tissue encountered by the parasite when it infects the vertebrate host. We therefore infected IL-7 cutaneous transgenic mice and compared several parasitological and immunological parameters to those of infected littermate controls. In transgenic mice, an increased number of total adult worms was observed while egg number and female fecundity remained unchanged. Additionally, transgenic animals displayed a more intensive hepatic fibrosis. In parallel, infected IL-7 transgenic animals showed a dominant Th2-type humoral response towards egg antigens. The results presented here confirm and reinforce the key role play by IL-7 in S. mansoni-vertebrate host interplay, beginning with keratinocyte-derived IL-7.


Subject(s)
Interleukin-7/immunology , Schistosomiasis mansoni/immunology , Animals , Cytokines/biosynthesis , Female , Interleukin-7/genetics , Liver/pathology , Mice , Mice, Transgenic , Ovum , Schistosoma mansoni/immunology , Schistosoma mansoni/isolation & purification , Schistosomiasis mansoni/parasitology , Skin/immunology , Th2 Cells/immunology
12.
Blood ; 97(5): 1435-41, 2001 Mar 01.
Article in English | MEDLINE | ID: mdl-11222391

ABSTRACT

Tyrosine kinase fusion oncogenes that occur as a result of chromosomal translocations have been shown to activate proliferative and antiapoptotic pathways in leukemic cells, but the importance of autocrine and paracrine expression of hematopoietic cytokines in leukemia pathogenesis is not understood. Evidence that leukemic transformation may be, at least in part, cytokine dependent includes data from primary human leukemia cells, cell culture experiments, and murine models of leukemia. This report demonstrates that interleukin (IL)-3 plasma levels are elevated in myeloproliferative disease (MPD) caused by the TEL/tyrosine kinase fusions TEL/platelet-derived growth factor beta receptor (PDGFbetaR), TEL/Janus kinase 2 (JAK2), and TEL/neurotrophin-3 receptor (TRKC). Plasma granulocyte-macrophage colony-stimulating factor (GM-CSF) levels were elevated by TEL/PDGFbetaR and TEL/JAK2. However, all of the fusions tested efficiently induced MPD in mice genetically deficient for both GM-CSF and IL-3, demonstrating that these cytokines are not necessary for the development of disease in this model system. Furthermore, in experiments using normal marrow transduced with TEL/PDGFbetaR retrovirus mixed with marrow transduced with an enhanced green fluorescent protein (EGFP) retrovirus, the MPD induced in these mice demonstrated minimal stimulation of normal myelopoiesis by the TEL/PDGFbetaR-expressing cells. In contrast, recipients of mixed GM-CSF-transduced and EGFP-transduced marrow exhibited significant paracrine expansion of EGFP-expressing cells. Collectively, these data demonstrate that, although cytokine levels are elevated in murine bone marrow transplant models of leukemia using tyrosine kinase fusion oncogenes, GM-CSF and IL-3 are not required for myeloproliferation by any of the oncogenes tested.


Subject(s)
Cell Transformation, Neoplastic/drug effects , Myeloproliferative Disorders/etiology , Oncogene Proteins, Fusion/pharmacology , Animals , Bone Marrow Transplantation , Cell Transformation, Neoplastic/genetics , Disease Models, Animal , Granulocyte-Macrophage Colony-Stimulating Factor/genetics , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Interleukin-3/genetics , Interleukin-3/pharmacology , Mice , Mice, Knockout , Myeloproliferative Disorders/pathology , Neoplasm Proteins/genetics , Neoplasm Proteins/pharmacology , Oncogene Proteins, Fusion/genetics , Paracrine Communication , Transduction, Genetic
13.
Metab Eng ; 2(4): 349-56, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11120646

ABSTRACT

A common metabolic complication of human disease is uncontrolled muscle protein breakdown or cachexia, which occurs in patients with chronic diseases such as cancer, AIDS, renal failure, and diabetes. Increased branched-chain amino acid catabolism is implicated as causal and has stimulated the investigation of methods to regulate the metabolism of these amino acids. Here we demonstrate doxycycline-controlled overexpression of a branched-chain alpha-ketoacid dehydrogenase (BCKD) kinase transgene in mammalian cell culture. This kinase functions to inactivate the BCKD complex by phosphorylation, thus preventing the catabolism of these essential, regulatory metabolites. In this study, doxycycline treatment leads to a 10-fold increase in BCKD kinase protein. The transgene-generated kinase is rapidly incorporated within mitochondria and functions correctly to inactivate the BCKD complex. The maximum reduction in basal BCKD activity achieved was 94%. Unexpectedly, total BCKD activity was also decreased by kinase overexpression despite no observable change in expression of the BCKD catalytic proteins. These results demonstrate that artificial regulation of branched-chain amino acid metabolism is possible through the controlled overexpression of a single endogenous enzyme and suggest the feasibility of clinical applications.


Subject(s)
Amino Acids, Branched-Chain/metabolism , Gene Expression Regulation, Enzymologic , Genetic Engineering , Protein Kinases/genetics , Protein Kinases/metabolism , 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) , Animals , Blotting, Western , CHO Cells , Cricetinae , Doxycycline/pharmacology , Gene Expression Regulation, Enzymologic/drug effects , Ketone Oxidoreductases/antagonists & inhibitors , Ketone Oxidoreductases/genetics , Ketone Oxidoreductases/metabolism , Mice , Mitochondria/drug effects , Mitochondria/enzymology , Mitochondria/genetics , Multienzyme Complexes/antagonists & inhibitors , Multienzyme Complexes/genetics , Multienzyme Complexes/metabolism , Phosphorylation/drug effects , Transfection , Transgenes/genetics
14.
Mol Cell ; 6(3): 693-704, 2000 Sep.
Article in English | MEDLINE | ID: mdl-11030348

ABSTRACT

STAT5 is activated in a broad spectrum of human hematologic malignancies. We addressed whether STAT5 activation is necessary for the myelo- and lymphoproliferative disease induced by TEL/JAK2 using a genetic approach. Whereas mice transplanted with bone marrow transduced with retrovirus expressing TEL/JAK2 develop a rapidly fatal myelo- and lymphoproliferative syndrome, reconstitution with bone marrow derived from Stat5ab-deficient mice expressing TEL/JAK2 did not induce disease. Disease induction in the Stat5a/b-deficient background was rescued with a bicistronic retrovirus encoding TEL/JAK2 and Stat5a. Furthermore, myeloproliferative disease was induced by reconstitution with bone marrow cells expressing a constitutively active mutant, Stat5a, or a single Stat5a target, murine oncostatin M (mOSM). These data define a critical role for Stat5a/b and mOSM in the pathogenesis of TEL/JAK2 disease.


Subject(s)
DNA-Binding Proteins/genetics , Lymphoproliferative Disorders/physiopathology , Milk Proteins , Myeloproliferative Disorders/physiopathology , Oncogene Proteins, Fusion/genetics , Trans-Activators/genetics , Animals , Blotting, Southern , Bone Marrow Cells/pathology , Bone Marrow Transplantation , Colony-Forming Units Assay , DNA, Neoplasm/analysis , Fibrosis , Flow Cytometry , Gene Transfer Techniques , Lymphoproliferative Disorders/genetics , Mice , Mice, Mutant Strains , Mutagenesis/physiology , Myeloproliferative Disorders/genetics , Neoplasm Transplantation , Oncostatin M , Peptides/genetics , Phenotype , Retroviridae/genetics , STAT5 Transcription Factor
15.
EMBO J ; 19(8): 1827-38, 2000 Apr 17.
Article in English | MEDLINE | ID: mdl-10775267

ABSTRACT

The TEL-TRKC fusion is expressed as a consequence of t(12;15)(p13;q25), and is associated with two human cancers: congenital fibrosarcoma and acute myelogenous leukemia (AML). We report that the T/T(F) and T/T(L) fusion variants associated with congenital fibrosarcoma and AML, respectively, are constitutively tyrosine phosphorylated, and confer factor-independent growth to the murine hematopoietic cell line Ba/F3. Retroviral transduction of T/T(L) causes a rapidly fatal myeloproliferative disease in a murine bone marrow transplant (BMT) model, whereas T/T(F) causes a long-latency, pre-B-cell lymphoblastic lymphoma. TEL-TRKC variants are potent activators of the MAP kinase pathway, but neither variant activates Stat5 or other Stat family members. T/T(L), but not T/T(F), induces tyrosine phosphorylation of phospholipase Cgamma (PLCgamma), phosphoinositol-3 kinase and SHC. However, mutation analysis demonstrates that PLCgamma tyrosine phos phorylation by T/T(L) is dispensable for induction of the myeloproliferative phenotype by T/T(L). Collectively, these data demonstrate that the TEL-TRKC fusion variants are oncoproteins that activate the MAP kinase pathway, and do not require activation of either PLCgamma or Stat5 for efficient induction of a myeloproliferative phenotype in the murine BMT model.


Subject(s)
Chromosomes, Human, Pair 12 , Chromosomes, Human, Pair 15 , DNA-Binding Proteins/metabolism , Fibrosarcoma/genetics , Leukemia, Myeloid, Acute/genetics , Milk Proteins , Oncogene Proteins, Fusion/metabolism , Receptor, trkC/metabolism , Repressor Proteins , Transcription Factors/metabolism , Translocation, Genetic , 3T3 Cells , Animals , Bone Marrow/metabolism , Cell Transformation, Neoplastic , Fibrosarcoma/congenital , Hematopoietic Stem Cells/metabolism , Humans , Isoenzymes/metabolism , MAP Kinase Signaling System , Mice , Muscle, Skeletal/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Phospholipase C gamma , Phosphorylation , Proto-Oncogene Proteins c-ets , STAT5 Transcription Factor , Signal Transduction , Tissue Distribution , Trans-Activators/metabolism , Tumor Cells, Cultured , Type C Phospholipases/metabolism , Tyrosine/metabolism , ETS Translocation Variant 6 Protein
16.
J Clin Invest ; 105(4): 423-32, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10683371

ABSTRACT

The t(5;12)(q33;p13) translocation associated with chronic myelomonocytic leukemia (CMML) generates a TEL/PDGFbetaR fusion gene. Here, we used a murine bone marrow transplant (BMT) assay to test the transforming properties of TEL/PDGFbetaR in vivo. TEL/PDGFbetaR, introduced into whole bone marrow by retroviral transduction, caused a rapidly fatal myeloproliferative disease that closely recapitulated human CMML. TEL/PDGFbetaR transplanted mice developed leukocytosis with Gr-1(+) granulocytes, splenomegaly, evidence of extramedullary hematopoiesis, and bone marrow fibrosis, but no lymphoproliferative disease. We assayed mutant forms of the TEL/PDGFbetaR fusion protein - including 8 tyrosine to phenylalanine substitutions at phosphorylated PDGFbetaR sites to which various SH2 domain-containing signaling intermediates bind - for ability to transform hematopoietic cells. All of the phenylalanine (F-) mutants tested conferred IL-3-independence to a cultured murine hematopoietic cell line, but, in the BMT assay, different F-mutants displayed distinct transforming properties. In transplanted animals, tyrosines 579/581 proved critical for the development of myeloproliferative phenotype. F-mutants with these residues mutated showed no sign of myeloproliferation but instead developed T-cell lymphomas. In summary, TEL/PDGFbetaR is necessary and sufficient to induce a myeloproliferative disease in a murine BMT model, and PDGFbetaR residues Y579/581 are required for this phenotype.


Subject(s)
Cell Transformation, Neoplastic , DNA-Binding Proteins/metabolism , Leukemia, Myelomonocytic, Acute/etiology , Oncogene Proteins, Fusion/metabolism , Receptors, Platelet-Derived Growth Factor/metabolism , Repressor Proteins , Transcription Factors/metabolism , Tyrosine/metabolism , Animals , Clone Cells , DNA-Binding Proteins/genetics , Gene Rearrangement, T-Lymphocyte , Gene Transfer Techniques , Genetic Vectors , Lymphoma, T-Cell , Mice , Mice, Inbred BALB C , Proto-Oncogene Proteins c-ets , Receptors, Platelet-Derived Growth Factor/genetics , Retroviridae/genetics , Signal Transduction , Syndrome , Tissue Transplantation , Transcription Factors/genetics , Virus Integration , ETS Translocation Variant 6 Protein
17.
Blood ; 93(5): 1707-14, 1999 Mar 01.
Article in English | MEDLINE | ID: mdl-10029600

ABSTRACT

The TEL/PDGFbetaR fusion protein is expressed as the consequence of a recurring t(5;12) translocation associated with chronic myelomonocytic leukemia (CMML). Unlike other activated protein tyrosine kinases associated with hematopoietic malignancies, TEL/PDGFbetaR is invariably associated with a myeloid leukemia phenotype in humans. To test the transforming properties of TEL/PDGFbetaR in vivo, and to analyze the basis for myeloid lineage specificity in humans, we constructed transgenic mice with TEL/PDGFbetaR expression driven by a lymphoid-specific immunoglobulin enhancer-promoter cassette. These mice developed lymphoblastic lymphomas of both T and B lineage, demonstrating that TEL/PDGFbetaR is a transforming protein in vivo, and that the transforming ability of this fusion is not inherently restricted to the myeloid lineage. Treatment of TEL/PDGFbetaR transgenic animals with a protein tyrosine kinase inhibitor with in vitro activity against PDGFbetaR (CGP57148) resulted in suppression of disease and a prolongation of survival. A therapeutic benefit was apparent both in animals treated before the development of overt clonal disease and in animals transplanted with clonal tumor cells. These results suggest that small-molecule tyrosine kinase inhibitors may be effective treatment for activated tyrosine kinase-mediated malignancies both early in the course of disease and after the development of additional transforming mutations.


Subject(s)
DNA-Binding Proteins/genetics , Enzyme Inhibitors/therapeutic use , Hematologic Neoplasms/drug therapy , Hematologic Neoplasms/genetics , Protein-Tyrosine Kinases/antagonists & inhibitors , Receptors, Platelet-Derived Growth Factor/genetics , Repressor Proteins , Transcription Factors/genetics , Translocation, Genetic , Animals , Antineoplastic Agents/therapeutic use , Mice , Mice, Transgenic , Proto-Oncogene Proteins c-ets , Receptor, Platelet-Derived Growth Factor beta , ETS Translocation Variant 6 Protein
18.
Eur J Immunol ; 28(12): 4221-7, 1998 12.
Article in English | MEDLINE | ID: mdl-9862359

ABSTRACT

Productive interactions between B7-1 and B7-2 costimulatory molecules on dendritic cells (DC) and CD28 on T cells are thought to be critical for successful antigen presentation. Epicutaneous application of haptens induces both contact hypersensitivity (CHS), an inflammatory cutaneous response mediated by CD8+ T cells, and an anti-hapten antibody response mediated by CD4+ helper T cells. The role of B7 costimulation in the immune response to oxazolone (Ox) was analyzed using mice lacking either B7-1 (B7-1-/-), B7-2 (B7-2-/-), or both (Db-/-) of these costimulatory molecules. The absence of both B7-1 and B7-2 results in diminished CHS. This inhibition is largely overcome at higher hapten sensitizing doses indicating the presence of compensatory pathways. In contrast, anti-Ox IgG1 and IgG2a responses were not detected in the absence of both B7-1 and B7-2, even at high sensitizing doses, indicating an obligatory role of B7 costimulation in IgG class switching. B7-1 and B7-2 have overlapping functions in both CHS responses and anti-hapten response. B7-2-/- mice demonstrated a modestly reduced CHS response only at very low doses of Ox (0.05%), but responded normally at higher Ox doses, and B7-1-/- mice had CHS responses indistinguishable from those of wild-type mice. Similarly, anti-Ox IgG responses were comparable in wild-type, B7-1-/- and B7-2-/- mice. Taken together, these studies reveal distinct roles for B7 costimulation in response to epicutaneous antigens with an obligatory role for IgG class switching and an important, but nonessential role for CHS responses.


Subject(s)
Antibody Formation , Antigens, CD/immunology , B7-1 Antigen/immunology , Dendritic Cells/immunology , Dermatitis, Contact/immunology , Membrane Glycoproteins/immunology , T-Lymphocytes/immunology , Animals , Antigen Presentation , B7-2 Antigen , Mice , Mice, Knockout , Oxazolone/immunology
19.
EMBO J ; 17(18): 5321-33, 1998 Sep 15.
Article in English | MEDLINE | ID: mdl-9736611

ABSTRACT

Recent reports have demonstrated fusion of the TEL gene on 12p13 to the JAK2 gene on 9p24 in human leukemias. Three variants have been identified that fuse the TEL pointed (PNT) domain to (i) the JAK2 JH1-kinase domain, (ii) part of and (iii) all of the JH2 pseudokinase domain. We report that all of the human TEL/JAK2 variants, and a human/mouse chimeric hTEL/mJAK2(JH1) fusion gene, transform the interleukin-3 (IL-3)-dependent murine hematopoietic cell line Ba/F3 to IL-3-independent growth. Transformation requires both the TEL PNT domain and JAK2 kinase activity. Furthermore, all TEL/JAK2 variants strongly activated STAT 5 by phosphotyrosine Western blots and by electrophoretic mobility shift assays (EMSA). Mice (n = 40) transplanted with bone marrow infected with the MSCV retrovirus containing either the hTEL/mJAK2(JH1) fusion or its human counterpart developed a fatal mixed myeloproliferative and T-cell lymphoproliferative disorder with a latency of 2-10 weeks. In contrast, mice transplanted with a TEL/JAK2 mutant lacking the TEL PNT domain (n = 10) or a kinase-inactive TEL/JAK2(JH1) mutant (n = 10) did not develop the disease. We conclude that all human TEL/JAK2 fusion variants are oncoproteins in vitro that strongly activate STAT 5, and cause lethal myelo- and lymphoproliferative syndromes in murine bone marrow transplant models of leukemia.


Subject(s)
Hematopoietic Stem Cells , Lymphoproliferative Disorders/genetics , Milk Proteins , Myeloproliferative Disorders/genetics , Oncogene Proteins, Fusion/genetics , Animals , Bone Marrow Transplantation , Cell Division , Cell Line, Transformed , DNA/metabolism , DNA, Recombinant , DNA, Viral/analysis , DNA-Binding Proteins/metabolism , Hematopoietic Stem Cells/cytology , Humans , Interleukin-3/physiology , Mice , Mice, Transgenic , Myeloproliferative Disorders/pathology , Oncogene Proteins, Fusion/physiology , Retroviridae/genetics , STAT5 Transcription Factor , Trans-Activators/metabolism , Transformation, Genetic , Virus Integration
20.
Clin Orthop Relat Res ; (356): 170-80, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9917682

ABSTRACT

Sterilization by gamma irradiation in air has been shown to have the potential to accelerate the oxidation of polyethylene components resulting in reduced mechanical properties. In the hip, it has been reported that the occurrence of delamination and cracking in retrieved bearings is significantly different when comparing components sterilized with gamma irradiation in air with components sterilized with ethylene oxide. Using a collection of 1635 retrieved polyethylene knee bearings, this study pursues a similar comparison of sterilization method with clinical wear in the knee. It confirms that retrieved polyethylene knee components that were gamma irradiated in air have a high incidence of delamination and cracking, leading at times to complete wear through of the bearing. Knee components sterilized with ethylene oxide showed no evidence of fatigue damage even after in vivo durations in excess of 15 years.


Subject(s)
Knee Prosthesis , Prosthesis Failure , Sterilization/methods , Biomechanical Phenomena , Ethylene Oxide , Gamma Rays , Humans , Oxidation-Reduction , Polyethylenes/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...